NCT02588456 · Interventional trial
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
Overall registry status Terminated
Phase 1
Conditions Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory